Can Ansay’s work with DrAnsay places him among Europe’s emerging digital health players, linking remote medical certification with cross-border access. His model raises economic and regulatory questions, as policymakers study how such services may ease system pressure while protecting standards in a global health economy.
VALLETA, MALTA / March 11, 2026 — Europe’s push toward a more connected health economy has opened space for new digital actors, and DrAnsay sits within that shift as one of several platforms seeking to link patients with medical services across borders.
Public information indicates that the company focuses on remote access to medical certificates and related services, positioning it in a growing market segment where policy, technology, and patient autonomy intersect in complex ways.
Observers in Europe have tracked rapid growth in telehealth-style offerings since the COVID-19 pandemic, with some studies noting sharp increases in remote consultations and electronic documentation.
DrAnsay participates in that environment by offering web-based sick notes and similar services that can be accessed from home, which shifts part of routine care away from traditional clinics while still needing to respect national labor and health laws. The company’s expansion into countries such as France, Brazil, Indonesia, and Italy signals a cross-border ambition that relies on careful reading of local regulations, since each jurisdiction maintains different rules for medical certification, data protection, and insurance recognition.
Regulators and professional bodies in Europe have responded with mixed reactions, citing both economic opportunity and concern over quality control, patient safety, and “Uber-isation” of medicine.
Critics in France and Germany, for example, have warned that remote sick-note services may put pressure on traditional systems if oversight is weak, while supporters argue that efficient documentation can reduce unnecessary clinic visits and ease burdens on primary care.
The broader debate reflects how ventures like DrAnsay test the limits of cross-border healthcare freedom: they create new channels for patients to reach licensed professionals, yet they compel policymakers to refine rules on telehealth, data use, and liability so that economic gains align with public interest.
About DrAnsay
DrAnsay is a European health technology company that provides remote access to medical certificates and related services within the growing digital health economy. The company has expanded from Germany into several international markets, positioning its platform at the center of ongoing policy debates about telehealth, cross-border access, and regulatory oversight in modern healthcare systems.
Contact Information
Contact Person: Jeanette Hepp
Company: DrAnsay Ltd.
Company Website: https://dransay.com/Email Address: jeanette@dransay.com
Location: Valletta, Malta
